Upstream Bio (UPB) Assets (2023 - 2026)

Upstream Bio has reported Assets for 4 years, with the latest figure at $318.1 million in Q1 2026.

• For the quarter ending Q1 2026, Assets fell 30.28% year-over-year to $318.1 million; the trailing twelve-month figure through Mar 2026 stood at $318.1 million (down 30.28% YoY), and the FY2025 full-year result was $353.8 million, down 26.56% from the prior year.
• Assets for Q1 2026 stood at $318.1 million, down from $353.8 million in the prior quarter.
• The five-year high for Assets was $481.7 million in Q4 2024, with the low at $117.2 million in Q4 2023.
• Average Assets over 4 years is $346.4 million, with a median of $372.5 million recorded in 2025.
• Year-over-year, Assets soared 311.03% in 2024 and sank 30.28% in 2026.
• Tracing UPB's Assets over 4 years: stood at $117.2 million in 2023, then surged by 311.03% to $481.7 million in 2024, then slipped by 26.56% to $353.8 million in 2025, then fell by 10.1% to $318.1 million in 2026.
• The last three Assets figures came in at $318.1 million (Q1 2026), $353.8 million (Q4 2025), and $391.2 million (Q3 2025), per Business Quant data.

Peer Comparison